ATE334137T1 - Ringerweiterte nukleoside und nukleotide - Google Patents
Ringerweiterte nukleoside und nukleotideInfo
- Publication number
- ATE334137T1 ATE334137T1 AT02001587T AT02001587T ATE334137T1 AT E334137 T1 ATE334137 T1 AT E334137T1 AT 02001587 T AT02001587 T AT 02001587T AT 02001587 T AT02001587 T AT 02001587T AT E334137 T1 ATE334137 T1 AT E334137T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions
- nucleosides
- ringer
- nucleotides
- extended
- Prior art date
Links
- 239000002777 nucleoside Substances 0.000 title 1
- 239000002773 nucleotide Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 206010017533 Fungal infection Diseases 0.000 abstract 1
- 208000031888 Mycoses Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000030852 Parasitic disease Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 230000002538 fungal effect Effects 0.000 abstract 1
- 208000006454 hepatitis Diseases 0.000 abstract 1
- 231100000283 hepatitis Toxicity 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 230000003071 parasitic effect Effects 0.000 abstract 1
- 150000003212 purines Chemical class 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/052—Imidazole radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12821293A | 1993-09-29 | 1993-09-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE334137T1 true ATE334137T1 (de) | 2006-08-15 |
Family
ID=22434211
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02001587T ATE334137T1 (de) | 1993-09-29 | 1994-09-29 | Ringerweiterte nukleoside und nukleotide |
| AT94929358T ATE223428T1 (de) | 1993-09-29 | 1994-09-29 | Nukleoside und nukleotide mit vergrösserten ringen |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94929358T ATE223428T1 (de) | 1993-09-29 | 1994-09-29 | Nukleoside und nukleotide mit vergrösserten ringen |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP0724587B8 (de) |
| AT (2) | ATE334137T1 (de) |
| AU (1) | AU7844594A (de) |
| CA (1) | CA2173116C (de) |
| DE (2) | DE69431304T2 (de) |
| DK (2) | DK1227103T3 (de) |
| ES (2) | ES2269528T3 (de) |
| PT (2) | PT1227103E (de) |
| WO (1) | WO1995009175A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6147056A (en) * | 1995-06-06 | 2000-11-14 | Trustees Of Boston University | Use of locally applied DNA fragments |
| US20030032610A1 (en) | 1996-06-03 | 2003-02-13 | Gilchrest Barbara A. | Method to inhibit cell growth using oligonucleotides |
| US5955059A (en) * | 1995-06-06 | 1999-09-21 | Trustees Of Boston University | Use of locally applied DNA fragments |
| US7094766B1 (en) | 1995-06-06 | 2006-08-22 | Trustees Of Boston University | Use of locally applied DNA fragments |
| AU2001251115A1 (en) | 2000-03-31 | 2001-10-15 | Trustees Of Boston University | Use of locally applied dna fragments |
| US6555581B1 (en) | 2001-02-15 | 2003-04-29 | Jones Pharma, Inc. | Levothyroxine compositions and methods |
| KR20040100835A (ko) | 2001-02-15 | 2004-12-02 | 킹 파머슈티칼스 리서치 앤드 디벨로프먼트 아이엔씨 | 안정된 제약및 갑상선 내분비 호르몬 구성물 및 그제조방법 |
| FR2825705B1 (fr) * | 2001-06-08 | 2005-05-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens |
| US7101569B2 (en) | 2001-08-14 | 2006-09-05 | Franz G Andrew | Methods of administering levothyroxine pharmaceutical compositions |
| FR2835186B1 (fr) | 2002-01-28 | 2006-10-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases |
| FR2844273B1 (fr) | 2002-09-05 | 2008-04-04 | Aventis Pharma Sa | Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens. |
| CN107074904B (zh) | 2014-10-23 | 2022-12-23 | 深圳华大智造科技股份有限公司 | 信号约束测序(scs)和用于信号约束测序的核苷酸类似物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60992B2 (ja) * | 1977-03-15 | 1985-01-11 | 財団法人微生物化学研究会 | コホルマイシンおよび関連物質の分離法 |
| US4163839A (en) * | 1977-12-09 | 1979-08-07 | Zaidan Hojin Biselbutsu Kagaku Kenkyu Kai | Isocoformycin and a process for the production thereof |
| US4935505A (en) * | 1983-05-03 | 1990-06-19 | Townsend Leroy B | Novel azolo [1,3] diazepine-5-ol compounds and their uses |
| US4713372A (en) * | 1984-03-16 | 1987-12-15 | Warner-Lambert Company | 2-chloropentostatin compound having adenosine diaminase inhibitory activity |
| IL108524A0 (en) * | 1993-02-03 | 1994-05-30 | Gensia Inc | Imidazodiazepine analogs |
-
1994
- 1994-09-29 EP EP94929358A patent/EP0724587B8/de not_active Expired - Lifetime
- 1994-09-29 AT AT02001587T patent/ATE334137T1/de not_active IP Right Cessation
- 1994-09-29 ES ES02001587T patent/ES2269528T3/es not_active Expired - Lifetime
- 1994-09-29 AT AT94929358T patent/ATE223428T1/de not_active IP Right Cessation
- 1994-09-29 PT PT02001587T patent/PT1227103E/pt unknown
- 1994-09-29 EP EP02001587A patent/EP1227103B1/de not_active Expired - Lifetime
- 1994-09-29 DE DE69431304T patent/DE69431304T2/de not_active Expired - Lifetime
- 1994-09-29 PT PT94929358T patent/PT724587E/pt unknown
- 1994-09-29 ES ES94929358T patent/ES2182847T3/es not_active Expired - Lifetime
- 1994-09-29 DK DK02001587T patent/DK1227103T3/da active
- 1994-09-29 AU AU78445/94A patent/AU7844594A/en not_active Abandoned
- 1994-09-29 WO PCT/US1994/010905 patent/WO1995009175A1/en not_active Ceased
- 1994-09-29 DK DK94929358T patent/DK0724587T3/da active
- 1994-09-29 CA CA002173116A patent/CA2173116C/en not_active Expired - Fee Related
- 1994-09-29 DE DE69434805T patent/DE69434805T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2173116A1 (en) | 1995-04-06 |
| PT1227103E (pt) | 2006-12-29 |
| DE69431304D1 (de) | 2002-10-10 |
| EP0724587A4 (de) | 1996-12-27 |
| DE69434805D1 (de) | 2006-09-07 |
| DE69434805T2 (de) | 2007-02-22 |
| EP0724587B1 (de) | 2002-09-04 |
| EP1227103A3 (de) | 2002-10-16 |
| PT724587E (pt) | 2003-01-31 |
| EP0724587A1 (de) | 1996-08-07 |
| WO1995009175A1 (en) | 1995-04-06 |
| ES2269528T3 (es) | 2007-04-01 |
| CA2173116C (en) | 2006-02-28 |
| ATE223428T1 (de) | 2002-09-15 |
| EP0724587B8 (de) | 2003-01-29 |
| EP1227103A2 (de) | 2002-07-31 |
| DK0724587T3 (da) | 2003-01-06 |
| DE69431304T2 (de) | 2003-05-15 |
| DK1227103T3 (da) | 2006-11-27 |
| ES2182847T3 (es) | 2003-03-16 |
| AU7844594A (en) | 1995-04-18 |
| EP1227103B1 (de) | 2006-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL101836A0 (en) | Pharmaceutical compositions containing 1,3-oxathiolane nucleoside derivatives | |
| MD1224B2 (en) | Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B | |
| MY109796A (en) | 1,3-oxathiolane nucleoside analogues. | |
| TW366347B (en) | Antiviral pharmaceutical compositions comprising 1,3-oxathiolane nucleoside analogues | |
| IL101144A0 (en) | Pharmaceutical compositions containing 1,3-oxathiolane nucleoside analogue and derivatives thereof for the treatment of hepatitis b virus infections | |
| RU93043875A (ru) | 1-(2-гидроксиметил)-1,3-оксатиолан-5-ил)-5-фторцитозин и способ лечения | |
| MD1838G2 (ro) | Derivaţi de 5,6-diclorbenzimidazol, procedeu de obţinere a lor, compoziţie farmaceutică şi metodă de tratament sau de prevenire a infecţiei virotice herpetice | |
| MY136229A (en) | Antiviral nucleoside derivatives | |
| ATE334137T1 (de) | Ringerweiterte nukleoside und nukleotide | |
| MY127808A (en) | Use of dideoxy nucleoside analogues in the treatment of viral infections | |
| MY105523A (en) | Substituted-1,3-oxathiolanes with antiviral properties. | |
| AU2003288869A1 (en) | PYRAZOLO (3,4-d) PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF H.PYLORI INFECTION | |
| IL85945A0 (en) | Pharmaceutical compositions containing 2'-fluoronucleosides and derivatives thereof,certain such novel compounds and their preparation | |
| MX9701273A (es) | Succinato de (4-(2-amino-6-(ciclopropilamino)-9h-purin-9-il)2-ciclopenten-1-metanol como agente antiviral. | |
| IE893991L (en) | 2',3'-dideoxypurine nucleoside/purine nucleoside¹phosphorylase inhibitor combination therapy and composition | |
| IE893080L (en) | Novel 2'-halomethylidene,2'-ethenylidene and¹2'-ethynyl adenosine derivatives | |
| CA2086756A1 (en) | Penciclovir and famciclovir and related guanine derivatives for the treatment of the hiv-1 infections | |
| MY137298A (en) | Therapeutic nucleosides | |
| IL92402A0 (en) | Pyrimidine nucleoside derivatives,their preparation and pharmaceutical compositions containing them | |
| ES2078380T3 (es) | Oligofosfatos de accion antiviral. | |
| MY103900A (en) | 6-substituted 2'', 3''-dideoxynucleosides and pharmaceutical compositions | |
| MY113560A (en) | Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis b | |
| RU93058540A (ru) | Производные 2-гидроксиметил-5-/5-фторцитозин-1-ил/-1,3-оксатиолан, фармкомпозиция, способы его получения, применение, способы лечения | |
| ES2067395A1 (es) | Derivados de nucleosidos o analogos a nucleosidos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1227103 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |